Voyager Therapeutics is a gene therapy company developing life-changing treatments for fatal and debilitating diseases of the central nervous system (CNS).
Audentes is a biotechnology company that employs gene therapy technology to develop treatments for people with rare muscle diseases.
iBio is a technology platform that develops pharmaceutical product applications.
Cepheid is a molecular diagnostics company providing molecular systems and tests for organisms and genetic-based diseases.
Genomic Health provides actionable genomic information to personalize cancer treatment decisions via the Oncotype DX tests.
AveXis is a biotech company developing innovative treatments for rare and life-threatening genetic diseases.
Intellia is developing therapeutic products to help people with genetic diseases.
Sequenom is the trusted source for genetic testing that guides reproductive health matters.
GenVec is a clinical-stage biopharmaceutical company focusing on developing a pipeline of therapeutics and vaccines through its proprietary AdenoVerse gene delivery platform.
OpGen focuses on commercializing solutions for DNA analysis and genomics with the Argus whole genome mapping system and MapIt services.
Marker Therapeutics (formerly known as TapImmune) develops immunotherapeutics to treat cancers, infectious diseases, autoimmune disorders, and transplant tissue rejection.
XENON® is a biopharmaceutical company focused on the development of novel medicines.